Purchase Order 140G0325P0041
Award Date
2/11/25
Potential Completion Date
4/6/26
Potential Value
$30K
Federal Agency
Office of Acquisitions and Grants
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anchorage, AK 99508, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the Office of Acquisitions and Grants, a civilian agency, to Illumina, Inc., a manufacturer of genomic sequencing instruments and solutions. The contract is for $71,643.00 to provide service maintenance for an Illumina MiSeq sequencer. The award has no set-aside designation and the period of performance runs through June 10, 2024. Illumina has a history of providing sequencing systems and related services to various government agencies,...
This is a firm fixed price purchase order contract awarded by the Office of Fossil Energy, a civilian agency, to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the renewal of a service agreement for an Illumina MiSeq sequencing system, with a period of performance from December 14, 2024 to December 13, 2026 and a ceiling value of $31,424.12. The contract does not have a set-aside designation. Illumina has previously received prime federal...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. government, to Illumina, Inc. for a service agreement for a NextSeq 2000 sequencing system. The total ceiling value of the contract is $48,209.00 and it has an ultimate completion date of December 15, 2025. This contract does not have a set-aside designation. Illumina is a manufacturer of genomic sequencing instruments and reagents, and...
This is a firm fixed price delivery order awarded by the Northeast Area of a Civilian federal agency to Illumina, Inc. for the purchase of on-site labor and parts to perform routine maintenance and repair services for the agency's Illumina MiSeq and NextSeq 2000 sequencing systems. The order has a ceiling value of $41,397.31 and an ultimate completion date of April 13, 2024. No set-aside was used. Illumina is a manufacturer of sequencing and array-based solutions for genetic and genomic...
This is a firm fixed price purchase order awarded by the Office of Acquisitions and Grants, a civilian agency, to Illumina, Inc. for annual support and maintenance services for the agency's MISEQ sequencing instruments. The contract has a ceiling value of $89,504.00 and a completion date of October 27, 2029. The award does not mention any set-aside designation. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has received previous prime and subcontract awards...
This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of a NextSeq sequencing system and has a ceiling value of $230,845.58. The contract has a period of performance ending on September 30, 2024. Illumina has previously been awarded prime contracts and subcontracts by various federal agencies, including the National Institutes...
This is a firm fixed price purchase order awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis equipment. The contract provides for an equipment maintenance agreement on Illumina sequencing systems, such as NextSeq, NovaSeq, MiSeq, and iSeq models, with a ceiling value of $16,198.00 and a performance period ending on December 4, 2025. The contract does...
This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to Illumina, Inc., a for-profit manufacturer of genomic sequencing systems and related products. The contract is for the provision of a NEXTSEQ 1000 SEQUENCING SYSTEM, with a potential value of $142,100.00. The contract does not have a set-aside designation and is expected to be completed by April 14, 2025. Illumina has...
This is a firm fixed-price purchase order contract awarded by the National Cancer Institute, a civilian agency within the National Institutes of Health, to Illumina, Inc. to maintain and provide preventive maintenance for an Illumina NextSeq 2000 sequencing system. The contract has a ceiling value of $48,209.00 and a performance period ending on March 19, 2026. Illumina is a manufacturer of genetic sequencing and analysis instruments and reagents, and has a history of providing such products and...
This firm fixed-price purchase order contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) Office of Logistics and Acquisition Operations to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and analytical products. The $24,728.01 contract is for the delivery of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample prep kits, and...